Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To investigate the effect and safety of budesonide Turbuhaler® 100 μg/dose and 200 μg/dose
twice daily for 6 weeks in Japanese children with bronchial asthma aged 5 years to 15 years
old in need for inhaled glucocorticosteroid treatment. To compare the efficacy of budesonide
Turbuhaler® 100 μg/dose and 200 μg/dose twice daily for 6 weeks to that of fluticasone
Diskus® 50 μg/dose and 100 μg/dose twice daily for 6 week.